Full Text
Efficiency Of Expenses Of Gefitinibum In Patients With Non-Small Cell Lung Cancer As A Second Line Therapy

Abstract

Authors

AV Rudakova DO Meshkov RU Khabriev LY Bezmelnitsyna

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×